Insulin sensitivity of glucose disposal and lipolysis: No influence of common genetic variants in IRS-1 and CAPN10

Diabetologia

Volumn 45, Issue 5, 2002, Pages 651-656

  Stumvoll, M ^a,b   Wahl, H ^a,b   Machicao, F ^a,b   Haring H ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Euglycaemic hyperinsulinaemic clamp; Glycerol; Insulin resistance; Lipolysis; Stable isotopes

Indexed keywords

GLUCOSE; GLYCEROL; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; STABLE ISOTOPE; CALPAIN; CALPAIN 10; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; PHOSPHOPROTEIN;

AGED; ARTICLE; BODY MASS; CLAMP; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIPOLYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; WILD TYPE; ADULT; DRUG EFFECT; GENETICS; GENOTYPE; GLUCOSE CLAMP TECHNIQUE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY; REFERENCE VALUE;

ADULT; BLOOD GLUCOSE; CALPAIN; FEMALE; GENOTYPE; GLUCOSE CLAMP TECHNIQUE; HUMAN; INFUSIONS, INTRAVENOUS; INSULIN; LIPOLYSIS; MALE; PHOSPHOPROTEINS; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T; VARIATION (GENETICS); HUMANS;

EID: 0035985086     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0793-x     Document Type: Article

References (33)

1. Pathogenesis of NIDDM
2. Carbohydrate metabolism in non-insulin-dependent diabetes mellitus
3. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: Problems and prospects
4. The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity
5. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
6. Multiple sites of insulin resistance: Muscle, liver and adipose tissue
7. Increased lipolysis and its consequences on gluconeogenesis in noninsulin-dependent diabetes mellitus
8. Fat metabolism in human obesity
9. Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity
10. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance
11. Insulin action and non-esterified fatty acids. The European Group for the Study of Insulin Resistance (EGIR)
12. The Pro12Ala polymorphism in the peroxisome proliferator activated receptor γ2 gene is associated with increased antilipolytic insulin sensitivity
13. Suppression of systemic, intramuscular and subcutaneous adipose tissue lipolysis by insulin in humans
14. A novel use of the hyperinsulinemic-euglycemic clamp technique to measure insulin sensitivity of systemic lipolysis
15. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance
16. Insulin resistance: Interactions between obesity and a common variant of insulin receptor substrate-1
17. Regulation of free fatty acid metabolism by insulin in humans: Role of lipolysis and reesterification
18. Amino acid polymorphism Gly 972 Arg in IRS-1 is not associated to lower clamp-derived insulin sensitivity in young healthy first degree relatives of patients with type 2 diabetes
19. On the hormonal regulation of carbohydrate metabolism: Studies with C14 glucose
20. Evidence that thyroid hormones regulate gluconeogenesis from glycerol in man
21. Relationship between insulin-mediated glucose disposal and lipid metabolism in man
22. Relationship between insulin-mediated glucose disposal by muscle and adipose tissue lipolysis in healthy volunteers
23. Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in the antilipolytic action of insulin
24. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate
25. The Gly-Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells
26. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies
27. UKPDS 19: Heterogeneity in NIDDM: Separate contributions of IRS- 1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study
28. Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus
29. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus
30. Insulin receptor substrate (IRS-1) gene polymorphisms in French NIDDM families
31. The common PPARg Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
32. The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose tolerant humans
33. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus